Publication | Closed Access
Ustekinumab improves health-related quality of life in Korean and Taiwanese patients with moderate to severe psoriasis: results from the PEARL trial.
18
Citations
0
References
2012
Year
Ustekinumab significantly improves HRQoL in Korean/Taiwanese patients with moderate to severe psoriasis.